Application: |
Peptide Synthesis: N-Me-Tyr(Me)-O.HCl can serve as a building block in solid-phase peptide synthesis (SPPS) or solution-phase peptide synthesis. It can be incorporated into peptide chains as a protected amino acid, enabling the creation of peptides with specific sequences. Peptides synthesized using N-Me-Tyr(Me)-O.HCl may have applications in drug development, biochemical research, and therapeutic interventions. Drug Development: Peptides containing modified tyrosine residues, such as N-Me-Tyr(Me), may exhibit unique pharmacological properties compared to their natural counterparts. They may have enhanced stability, altered receptor selectivity, or improved bioavailability. Therefore, they are of interest in drug development efforts targeting various diseases such as cancer, inflammation, and neurological disorders. Biological Research: N-Me-Tyr(Me)-O.HCl can be used in biochemical and biological studies to investigate protein structure and function. Incorporating modified tyrosine residues into peptides or proteins can help elucidate their roles in biological processes, protein-protein interactions, and signal transduction pathways. Additionally, peptides containing modified tyrosine residues may serve as probes for studying cellular signaling and disease mechanisms. |
China
